Clinical Trials Logo

Clinical Trial Summary

Identification of factors limiting compliance with the recommendations established during the evaluation of the SCORIC population by the rheumatology department of the CHU Grenoble Alpes


Clinical Trial Description

In the rheumatology department of the CHU Grenoble Alpes, Professor Baillet and other rheumatologists have set up a holistic assessment of inflammatory rheumatism (rheumatoid arthritis, spondyloarthritis and psoriatic arthritis) and associated co-morbidities in a day hospital. Based on this assessment, a hospital report is drawn up summarising the patient's treatment options, which is then sent to the patient's referring physician. They analysed the first 100 patients in the cohort and showed that 98% of patients were not up to date with their care. Their longitudinal analysis shows that patients update two thirds of the recommendations made within 12 to 18 months. Therefore, the investigators would like to assess the applicability of this screening in these patients, through a questionnaire sent to the 400 patients of the cohort and to their treating physicians. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05613712
Study type Observational
Source University Hospital, Grenoble
Contact Athan BAILLET, PU-PH
Phone 0476767082
Email abaillet@chu-grenoble.fr
Status Recruiting
Phase
Start date February 11, 2023
Completion date February 11, 2024

See also
  Status Clinical Trial Phase
Completed NCT04327752 - Skin Adverse Reactions Occuring in Children Treated by Biotherapy for Chronic Inflammatory Disease
Recruiting NCT04334031 - Deployment o the Multidisciplinary Prospective Cohort Imminent N/A
Active, not recruiting NCT02332460 - Infusion Related Reactions in Patients Receiving Infliximab
Terminated NCT05323110 - Study of Intravenously Administered Anti-LIGHT Monoclonal Antibody CBS001 in Healthy Volunteers Phase 1